Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 41 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2020Cauda Equina Syndrome Core Outcome Set (CESCOS): an international patient and healthcare professional consensus for research studiesSrikandarajah, N.; Noble, A.; Clark, S.; Wilby, M.; Freeman, B.J.C.; Fehlings, M.G.; Williamson, P.R.; Marson, T.; Romao, R.
2020Associations between area socioeconomic status, individual mental health, physical activity, diet and change in cardiometabolic risk amongst a cohort of Australian adults: a longitudinal path analysisCarroll, S.J.; Dale, M.J.; Niyonsenga, T.; Taylor, A.W.; Daniel, M.; Suominen, S.
2020Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019Wang, H.; Abbas, K.M.; Abbasifard, M.; Abbasi-Kangevari, M.; Abbastabar, H.; Abd-Allah, F.; Abdelalim, A.; Abolhassani, H.; Abreu, L.G.; Abrigo, M.R.M.; Abushouk, A.I.; Adabi, M.; Adair, T.; Adebayo, O.M.; Adedeji, I.A.; Adekanmbi, V.; Adeoye, A.M.; Adetokunboh, O.O.; Advani, S.M.; Afshin, A.; et al.
2020Developmental origins of cardiometabolic health outcomes in twins: a systematic review and meta-analysisAshtree, D.N.; McGuinness, A.J.; Plummer, M.; Sun, C.; Craig, J.M.; Scurrah, K.J.
2021Strain-Guided Management of Potentially Cardiotoxic Cancer TherapyThavendiranathan, P.; Negishi, T.; Somerset, E.; Negishi, K.; Penicka, M.; Lemieux, J.; Aakhus, S.; Miyazaki, S.; Shirazi, M.; Galderisi, M.; Marwick, T.H.
2021Dual antiangiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II studyMooi, J.; Chionh, F.; Savas, P.; Da Gama Duarte, J.; Chong, G.; Brown, S.; Wong, R.; Price, T.J.; Wann, A.; Skrinos, E.; Mariadason, J.M.; Tebbutt, N.C.
2020Coal-mine fire-related fine particulate matter and medical-service utilization in Australia: a time-series analysis from the Hazelwood Health StudyJohnson, A.L.; Gao, C.X.; Dennekamp, M.; Williamson, G.J.; Carroll, M.T.C.; Dimitriadis, C.; Dipnall, J.F.; Ikin, J.F.; Johnston, F.H.; McFarlane, A.C.; Sim, M.R.; Stub, D.A.; Abramson, M.J.; Guo, Y.
2021Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemiaOchi, Y.; Yoshida, K.; Huang, Y.-J.; Kuo, M.-C.; Nannya, Y.; Sasaki, K.; Mitani, K.; Hosoya, N.; Hiramoto, N.; Ishikawa, T.; Branford, S.; Shanmuganathan, N.; Ohyashiki, K.; Takahashi, N.; Takaku, T.; Tsuchiya, S.; Kanemura, N.; Nakamura, N.; Ueda, Y.; Yoshihara, S.; et al.
2020Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019GBD 2019 Diseases and Injuries Collaborators,; Baune, B.; Bhandari, D.; Ciobanu, L.; Lalloo, R.; Lassi, Z.; Noubiap Nzeale, J.
2021AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancerOar, A.; Lee, M.; Le, H.; Wilson, K.; Aiken, C.; Chantrill, L.; Simes, J.; Nguyen, N.; Barbour, A.; Samra, J.; Sjoquist, K.M.; Moore, A.; Espinoza, D.; Gebski, V.; Yip, S.; Chu, J.; Kneebone, A.; Goldstein, D.